111 related articles for article (PubMed ID: 32148004)
1. [New early gastric cancer marker PRDX4 promote the tumorigenesis and progression of gastric cancer via eliminating ROS].
Jia R; Shi D; Li W; Yang J; Zhang Y; Han Y
Sheng Wu Gong Cheng Xue Bao; 2020 Feb; 36(2):320-331. PubMed ID: 32148004
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of PRDX4 Modulates Tumor Microenvironment and Promotes Urethane-Induced Lung Tumorigenesis.
Zheng J; Guo X; Nakamura Y; Zhou X; Yamaguchi R; Zhang J; Ishigaki Y; Uramoto H; Yamada S
Oxid Med Cell Longev; 2020; 2020():8262730. PubMed ID: 33456675
[TBL] [Abstract][Full Text] [Related]
3. PRDX4 and Its Roles in Various Cancers.
Jia W; Chen P; Cheng Y
Technol Cancer Res Treat; 2019 Jan; 18():1533033819864313. PubMed ID: 31311441
[TBL] [Abstract][Full Text] [Related]
4. In silico analysis reveals PRDX4 as a prognostic and oncogenic marker in renal papillary cell carcinoma.
Kocatürk B
Gene; 2023 Apr; 859():147201. PubMed ID: 36646187
[TBL] [Abstract][Full Text] [Related]
5. Protective Effects of Peroxiredoxin 4 (PRDX4) on Cholestatic Liver Injury.
Zhang J; Guo X; Hamada T; Yokoyama S; Nakamura Y; Zheng J; Kurose N; Ishigaki Y; Uramoto H; Tanimoto A; Yamada S
Int J Mol Sci; 2018 Aug; 19(9):. PubMed ID: 30149550
[TBL] [Abstract][Full Text] [Related]
6. Peroxiredoxin 4 inhibits IL-1β-induced chondrocyte apoptosis via PI3K/AKT signaling.
Rao Z; Wang S; Wang J
Biomed Pharmacother; 2017 Jun; 90():414-420. PubMed ID: 28391163
[TBL] [Abstract][Full Text] [Related]
7. PRDX4 overexpression is associated with poor prognosis in gastric cancer.
Park SY; Lee YJ; Park J; Kim TH; Hong SC; Jung EJ; Ju YT; Jeong CY; Park HJ; Ko GH; Song DH; Park M; Yoo J; Jeong SH
Oncol Lett; 2020 May; 19(5):3522-3530. PubMed ID: 32269626
[TBL] [Abstract][Full Text] [Related]
8. Peroxiredoxin 5 overexpression enhances tumorigenicity and correlates with poor prognosis in gastric cancer.
Kim B; Kim YS; Ahn HM; Lee HJ; Jung MK; Jeong HY; Choi DK; Lee JH; Lee SR; Kim JM; Lee DS
Int J Oncol; 2017 Jul; 51(1):298-306. PubMed ID: 28535004
[TBL] [Abstract][Full Text] [Related]
9. Interplay Between Mitochondrial Peroxiredoxins and ROS in Cancer Development and Progression.
Ismail T; Kim Y; Lee H; Lee DS; Lee HS
Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31500275
[TBL] [Abstract][Full Text] [Related]
10. Helicobacter pylori infection promotes Aquaporin 3 expression via the ROS-HIF-1α-AQP3-ROS loop in stomach mucosa: a potential novel mechanism for cancer pathogenesis.
Wen J; Wang Y; Gao C; Zhang G; You Q; Zhang W; Zhang Z; Wang S; Peng G; Shen L
Oncogene; 2018 Jun; 37(26):3549-3561. PubMed ID: 29563612
[TBL] [Abstract][Full Text] [Related]
11. Peroxiredoxin V Inhibits Emodin-induced Gastric Cancer Cell Apoptosis
Jin YZ; Sun HN; Liu Y; Lee DH; Kim JS; Kim SU; Jiao BY; Han YH; Jin MH; Shen GN; Lee DS; Kwon T; Xu DY; Jin YU
In Vivo; 2019; 33(4):1183-1192. PubMed ID: 31280208
[TBL] [Abstract][Full Text] [Related]
12. Peroxiredoxin 4 (PRDX4): Its critical in vivo roles in animal models of metabolic syndrome ranging from atherosclerosis to nonalcoholic fatty liver disease.
Yamada S; Guo X
Pathol Int; 2018 Feb; 68(2):91-101. PubMed ID: 29341349
[TBL] [Abstract][Full Text] [Related]
13. Implication of Differential Peroxiredoxin 4 Expression with Age in Ovaries of Mouse and Human for Ovarian Aging.
Qian Y; Shao L; Yuan C; Jiang CY; Liu J; Gao C; Gao L; Cui YG; Jiang SW; Liu JY; Meng Y
Curr Mol Med; 2016; 16(3):243-51. PubMed ID: 26917265
[TBL] [Abstract][Full Text] [Related]
14. Reactive Oxygen Species-Mediated Tumor Microenvironment Transformation: The Mechanism of Radioresistant Gastric Cancer.
Gu H; Huang T; Shen Y; Liu Y; Zhou F; Jin Y; Sattar H; Wei Y
Oxid Med Cell Longev; 2018; 2018():5801209. PubMed ID: 29770167
[TBL] [Abstract][Full Text] [Related]
15. Estrogen potentiates reactive oxygen species (ROS) tolerance to initiate carcinogenesis and promote cancer malignant transformation.
Tian H; Gao Z; Wang G; Li H; Zheng J
Tumour Biol; 2016 Jan; 37(1):141-50. PubMed ID: 26566628
[TBL] [Abstract][Full Text] [Related]
16. Validation of the interaction between PRDX4 and TXNDC5 in gastric cancer and the significance of the
Zhang L; Wu K; Hou Y; Li X
Transl Cancer Res; 2024 Jan; 13(1):81-101. PubMed ID: 38410208
[TBL] [Abstract][Full Text] [Related]
17. Peroxiredoxin 4 promotes embryonal hepatoblastoma cell migration but induces fetal cell differentiation.
Zheng J; Guo X; Shioya A; Yoshioka T; Matsumoto K; Hiraki T; Kusano H; Oyama T; Kurose N; Yamaguchi R; Uramoto H; Ieiri S; Okajima H; Kohno M; Yamada S
Am J Transl Res; 2020; 12(6):2726-2737. PubMed ID: 32655804
[TBL] [Abstract][Full Text] [Related]
18. Effective Killing of Cancer Cells Through ROS-Mediated Mechanisms by AMRI-59 Targeting Peroxiredoxin I.
Yang YJ; Baek JY; Goo J; Shin Y; Park JK; Jang JY; Wang SB; Jeong W; Lee HJ; Um HD; Lee SK; Choi Y; Rhee SG; Chang TS
Antioxid Redox Signal; 2016 Mar; 24(8):453-69. PubMed ID: 26528922
[TBL] [Abstract][Full Text] [Related]
19. Peroxiredoxins 3 and 4 are overexpressed in prostate cancer tissue and affect the proliferation of prostate cancer cells in vitro.
Ummanni R; Barreto F; Venz S; Scharf C; Barett C; Mannsperger HA; Brase JC; Kuner R; Schlomm T; Sauter G; Sültmann H; Korf U; Bokemeyer C; Walther R; Brümmendorf TH; Balabanov S
J Proteome Res; 2012 Apr; 11(4):2452-66. PubMed ID: 22424448
[TBL] [Abstract][Full Text] [Related]
20. Gene methylation in gastric cancer.
Qu Y; Dang S; Hou P
Clin Chim Acta; 2013 Sep; 424():53-65. PubMed ID: 23669186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
